Amylgen and Neuron Experts Announce Exclusive, Strategic Partnership

The two preclinical CROs, well-known for their unique models and expertise in CNS pathologies, partner to provide a new combined in-vitro & in-vivo preclinical offer for a rapid efficacy assessment of compounds in neurodegenerative diseases. MONTPELLIER & MARSEILLE – December 10, 2019 Amylgen and Neuron-Experts, two leading preclinical CROs specialized in CNS pathologies, today announced… Read more